WeVote
Log In

Bill

Bill

HB 3833

Blood autologous; Oklahoma Autologous and Directed Blood Donation Act; terms; physician orders; hospital responsibilities; blood bank responsibilities; administrative fees; liability protections; promulgation of rules; State Department of Health; effective date.

2026 Regular Session Introduced by Stan May

Oklahoma bill establishes legal framework for patient self-donation and designated-donor blood programs, creating new hospital/blood bank protocols and liability protections.

Referred to Public Health
0
WeVote Research Nonpartisan
Bill Summary · HB 3833

Legislative bill overview

HB 3833 establishes the Oklahoma Autologous and Directed Blood Donation Act, which creates a legal framework allowing patients to donate their own blood (autologous donation) or receive blood from designated donors (directed donation) before scheduled medical procedures. The bill defines terms, outlines physician ordering requirements, specifies hospital and blood bank responsibilities, establishes administrative fee structures, and provides liability protections for medical institutions participating in these donation programs.

Why is this important

Autologous and directed blood donation programs can reduce patients' exposure to transfusion-related risks and may provide psychological reassurance for those with religious or personal objections to standard blood bank transfusions. However, the bill's passage would significantly reshape blood management practices in Oklahoma hospitals, potentially affecting inventory management, operational costs, and the viability of traditional community blood donation programs that rely on altruistic donors.

Potential points of contention

  • Blood safety and efficiency: Autologous programs require separate collection, storage, and tracking systems; medical professionals debate whether these programs improve outcomes or create unnecessary complexity and waste when blood isn't ultimately used
  • Impact on blood donation infrastructure: Diverting donors toward autologous collection could reduce donations to community blood banks, potentially creating shortages for emergency transfusions and vulnerable patient populations
  • Liability protections scope: The bill grants liability protections to medical institutions, which may shield providers from accountability if complications arise from autologous/directed donation procedures, raising consumer protection concerns

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.